LPCN 1148 is an oral prodrug of bioidentical testosterone containing testosterone dodecanoate, an androgen receptor agonist.

Sarcopenia is believed to be associated with a poorer prognosis in patients with cirrhosis. Objective: To evaluate the impact of sarcopenia on the prognosis of patients hospitalized for acute ...

Liver cirrhosis was observed in 24.8% of patients. Outcomes included HCC, decompensation, and LT or death, and the mean follow-up was 34.8 months. These findings suggest the potential of TAF ...

Therefore, the aim of the present pilot study was to investigate the feasibility of repetitive SSM and its clinical usefulness after initiation of recompensation measures in patients with cirrhosis ...

This systematic review evaluates the safety, efficacy, and outcomes of OP IV diuresis in managing decompensated HF as a hospitalization alternative. Methods: Following PRISMA 2020 guidelines, this ...

additional follow-up data are needed before a recommendation can be made regarding the need to continue lamivudine after initiation of adefovir in patients with decompensated HBV-cirrhosis.

This Review will focus on the opportunities and advancements in digital health care applied to patients with cirrhosis who are at risk of complications, namely those with decompensated cirrhosis. We ...

Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect ...

OCALIVA is contraindicated in PBC patients with decompensated cirrhosis, a prior decompensation event, or with compensated cirrhosis who have evidence of portal hypertension. Permanently ...